Why GcMAF Forte

THE NEW AGE OF CANCER IMMUNOTHERAPY

What GcMAF Forte can do for you

Supplementing your body with GcMAF Forte helps stimulate the macrophages in your system. Macrophages are specialized cells in the immune system formed in response to an infection or accumulating damaged or dead cells. They are able identify, engulf and destroy target cells. Activating macrophages enables the synthesis of:

  • Antitumor cytokines such as interleukin-12 (IL12) and tumor necrosis factor (TNF)
  • IFN-gamma (interferon), nitric oxide, reactive oxygen compounds, cationic proteins, and hydrolytic enzymes.

 

GcMAF Forte provides individualised immunotherapy for:

 

Cancer with Solid Tumors
(Breast, Prostate, Colorectal, Ovarian etc.)

  • Decrease progression of tumor
  • Blocks cancer cell-induced angiogenesis (the blood supply to tumours)
  • Initiates apoptosis – suicide of cancer cells
  • Eliminates production of immunosuppressive factors by tumour

Immunodeficiency and Infectious Diseases
(HIV, Herpes, Lyme etc.)

  • Inhibits inflammation
  • Improve immune system response

Chronic Fatigue Syndrome

  • Reduction of chronic pain.
  • Increased energy production at the mitochondrial level.
  • Neuroprotective effects.
  • Stimulation of adult neurogenesis.

 

 

RESOURCES

 

Management of Metastatic Colorectal Carcinoma with GcMAF Forte and Thymus Peptides

Management of Metastatic Colorectal Carcinoma with GcMAF Forte and Thymus Peptides: A Case Report

Author/s: Dr. Dmitry Klokol et al.
Published at Journal of Clinical & Cellular Immunology.
Published URL: omicsonline.org
Download PDF click here.

Active Specific Immunotherapy (ASI) and Gcmaf Forte in Management of Metastatic Invasive Carcinoma

Active Specific Immunotherapy (ASI) and Gcmaf Forte in Management of Metastatic Invasive Carcinoma – Overview of the Therapeutic Modalities and A case Report

Author/s: Dr Roni L. Moya, Prof. Dr. Mike Chan, Dr. Dmitry Klokol and Dr. Shing Yi Pan.
Published at  Journal of Clinical & Experimental Immunology, 19 November 2018, Review Article ISSN: 2475-6296, Volume 3, Issue 2
Published URL: https://www.opastonline.com/wp-content/uploads/2018/11/active-specific-immunotherapy-asi-and-gcmaf-forte-in-management-of-metastatic-invasive-carcinoma%E2%80%93overview-of-the-therapeutic-modalities-and-a-case-repor-jcei-18.pdf
Download PDF click here.

 

 

 

 

 

JOIN US ON
Other Products
Useful Links
© 2023 GcMAF FORTE| LABRMS. ALL RIGHT RESERVED.   PRIVACY POLICY / TERMS & CONDITIONS